CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 4 enrolled
Drug / intervention
Trichuris suis ovadrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01433471
NCT01433471N/ACompleted
CompareCT.gov

Mucosal Immunity of Ulcerative Colitis Patients Undergoing Therapy With Trichuris Suis Ova

NYU Langone Health·interventional·Posted Sep 14, 2011·Updated Jul 1, 2016

In Brief

A clinical study evaluating Trichuris suis ova for Ulcerative Colitis. Completed, enrolled 4 participants across 1 site.

Detailed Summary

The purpose of this study is to understand the immune response activated in the human gastrointestinal tract by Trichuris Suis Ova (TSO) in patients with ulcerative colitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUlcerative Colitis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedSep 14, 2011
Enrollment StartAug 1, 2012
Primary CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 14.8 years ago

Interventions

Trichuris suis ovadrug

2,500 eggs by mouth every two weeks for 12 weeks